Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × temsirolimus × 1 year × Clear all

Sponsor

Conditions

Neoplasms 4 Neoplasm Metastasis 3 Sarcoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Pharyngeal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Neurofibromatosis 2 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Mesothelial 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Erdheim-Chester Disease 1 Endometrial Adenocarcinoma 1 Endocrine Gland Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡